UNSPSC 51283110: Clofazimine

This classification denotes an antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D959AE5USF. European Medicines Agency schedules Clofazimine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06694MIG. Clofazimine generally arises in the molecular formula C27H22CL2N4. The term CLOFAZIMINE is an International Non-Proprietary Name or INN. CLOFAZIMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

SMILES: CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)CL)C=C1NC5=CC=C(C=C5)CL.

UNSPSC 51283110 Clofazimine is a Commodity code for a specific pharmaceutical product, but the recent state and local opportunities posted under this code do not align with clofazimine procurement. Instead, the tagged opportunities document purchases of unrelated pharmaceuticals: Illinois Department of Public Health's award to Chartwell Rx LLC for Doxycycline Hyclate and Ciprofloxacin Hydrochloride through the MMCAP Infuse cooperative purchasing vehicle, and Seminole County, Florida's solicitation for Naloxone and drug deactivation systems. The code shows minimal genuine activity relevant to clofazimine itself, which is used primarily in treatment of leprosy and certain atypical mycobacterial infections — a narrow clinical application unlikely to drive frequent state and local procurement.

The geographic footprint across recent opportunities spans Florida and Illinois, though neither jurisdiction appears to be soliciting clofazimine specifically. Illinois Department of Public Health completed a $2,999,999.11 award (covering 12 months plus two renewal options) through an Invitation for Bid process, while Seminole County released a competitive IFB with a July 26, 2023 response deadline for its naloxone and deactivation-systems purchase. State and local health departments and county health systems represent the typical issuing bodies when pharmaceutical procurement occurs under this code, but the mismatch between the code's nominal scope and actual recent opportunities signals that clofazimine demand through state and local procurement remains dormant or is being tagged with different UNSPSC codes.